Cargando…
Cabergoline Tapering Is Almost Always Successful in Patients With Macroprolactinomas
CONTEXT: Cabergoline (CAB) is very effective in the treatment of macroprolactinomas, but there are few data on the CAB dose necessary to achieve and maintain normal prolactin (PRL) levels. DESIGN AND PATIENTS: We retrospectively studied 260 patients. CAB was introduced at a mean dose of 0.83 ± 0.52...
Autores principales: | Paepegaey, Anne-Cécile, Salenave, Sylvie, Kamenicky, Peter, Maione, Luigi, Brailly-Tabard, Sylvie, Young, Jacques, Chanson, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686686/ https://www.ncbi.nlm.nih.gov/pubmed/29264479 http://dx.doi.org/10.1210/js.2017-00038 |
Ejemplares similares
-
Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study
por: Kuhn, Emmanuelle, et al.
Publicado: (2015) -
Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LAR
por: Wolf, Peter, et al.
Publicado: (2022) -
Cabergoline therapy for Macroprolactinoma during pregnancy: A case report
por: Shahzad, Hira, et al.
Publicado: (2012) -
Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
por: Lee, Youngki, et al.
Publicado: (2014) -
A macroprolactinoma becoming resistant to cabergoline and developing
atypical pathology
por: Sbardella, Emilia, et al.
Publicado: (2016)